| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3200539 | Journal of Allergy and Clinical Immunology | 2008 | 12 Pages |
Abstract
There are currently no universally accepted AMPs. The available evidence to support use of self-management plans is encouraging but is, in comparison with other long-term conditions, such as asthma, extremely weak. The effectiveness and cost-effectiveness of AMPs need to be formally evaluated.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Ulugbek MD, PhD, Allison BSc (Hons), PhD, Aziz MD, FRCP,